RIPTACs: A groundbreaking approach to drug discovery

Zonghui Ma1, Andrew A Bolinger1, Jia Zhou1

  • 1Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA.

Drug Discovery Today
|September 21, 2023
PubMed

Insights

Regulated induced proximity targeting chimeras (RIPTACs) offer a novel approach to cancer therapy by selectively eliminating cancer cells. This groundbreaking strategy targets cancer-specific proteins to disrupt essential cell functions, leading to cancer cell death.

Area of Science:

  • Drug discovery and development
  • Molecular oncology
  • Biotechnology

Background:

  • Regulated induced proximity targeting chimeras (RIPTACs) are emerging heterobifunctional molecules.
  • RIPTACs selectively target cancer cells by forming complexes with cancer-specific target proteins (TPs) and essential effector proteins (EPs).

Purpose of the Study:

  • To review the discovery and recent advancements in RIPTAC technology.
  • To discuss the opportunities and challenges associated with RIPTAC-based cancer therapies.
  • To explore future perspectives in the field of RIPTACs.

Main Methods:

  • This review summarizes existing literature on RIPTACs.
  • It analyzes the mechanism of action for RIPTACs in cancer cell elimination.
  • The review discusses the potential for targeting a broad range of cancer types.

Main Results:

  • RIPTACs demonstrate a promising strategy for cancer cell-specific elimination.
  • The mechanism involves targeted disruption of effector proteins essential for cell survival.
  • TPs do not require a direct link to disease progression, expanding therapeutic targets.

Conclusions:

  • RIPTACs represent a groundbreaking approach in cancer drug discovery.
  • This strategy offers a method for selective cancer cell killing with minimal harm to healthy cells.
  • Further research and development hold significant promise for RIPTACs in oncology.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
757
Patch Clamp01:18

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
5.5K